Related content

Rational drug design: - Making drugs that make a difference

By Hayry P.   du Toit D.   Sarwal M.   Aavik E.   Hoffren A.   Vamvakopoulos J.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2000-2002

Elsevier

Access to resources Recommend Favorite

Why can't we make an effective vaccine against Helicobacter pylori?

By Sutton Philip   Chionh Yok Teng  

Expert Review of Vaccines, Vol. 12, Iss. 4, 2013-04 ,pp. : 433-441

Informa Healthcare

Access to resources Recommend Favorite

Can we make the predonation screening process more effective?

By  

ISBT SCIENCE SERIES, Vol. 11, Iss. S1, 2016-01 ,pp. : 62-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

ATG Induction Therapy and the Incidence of Bronchiolitis Obliterans After Lung Transplantation: Does It Make a Difference?

By Wiebe K.   Harringer W.   Wahlers T.   Franke U.   Struber M.   Hamm M.   Cremer J.   Haverich A.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1517-1518

Elsevier

Access to resources Recommend Favorite

Response to Buratti et al.: Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better?

By Eperon I.C.   Muntoni F.  

Trends in Molecular Medicine, Vol. 9, Iss. 6, 2003-06 ,pp. : 233-234

Elsevier

Access to resources Recommend Favorite